1,073
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US

, &
Pages 82-87 | Received 03 Nov 2023, Accepted 11 Dec 2023, Published online: 14 Dec 2023